1. Home
  2. DCTH vs HNST Comparison

DCTH vs HNST Comparison

Compare DCTH & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • HNST
  • Stock Information
  • Founded
  • DCTH 1988
  • HNST 2012
  • Country
  • DCTH United States
  • HNST United States
  • Employees
  • DCTH N/A
  • HNST N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • HNST Catalog/Specialty Distribution
  • Sector
  • DCTH Health Care
  • HNST Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • HNST Nasdaq
  • Market Cap
  • DCTH 388.3M
  • HNST 408.4M
  • IPO Year
  • DCTH N/A
  • HNST 2021
  • Fundamental
  • Price
  • DCTH $11.10
  • HNST $3.88
  • Analyst Decision
  • DCTH Strong Buy
  • HNST Buy
  • Analyst Count
  • DCTH 4
  • HNST 5
  • Target Price
  • DCTH $24.50
  • HNST $6.75
  • AVG Volume (30 Days)
  • DCTH 681.8K
  • HNST 3.9M
  • Earning Date
  • DCTH 11-07-2025
  • HNST 11-11-2025
  • Dividend Yield
  • DCTH N/A
  • HNST N/A
  • EPS Growth
  • DCTH N/A
  • HNST N/A
  • EPS
  • DCTH 0.06
  • HNST 0.06
  • Revenue
  • DCTH $70,240,000.00
  • HNST $389,783,000.00
  • Revenue This Year
  • DCTH $159.22
  • HNST $6.68
  • Revenue Next Year
  • DCTH $42.78
  • HNST $4.81
  • P/E Ratio
  • DCTH $197.68
  • HNST $63.87
  • Revenue Growth
  • DCTH 491.35
  • HNST 9.58
  • 52 Week Low
  • DCTH $8.08
  • HNST $3.32
  • 52 Week High
  • DCTH $18.23
  • HNST $8.97
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 45.00
  • HNST 48.92
  • Support Level
  • DCTH $10.43
  • HNST $3.49
  • Resistance Level
  • DCTH $11.28
  • HNST $4.03
  • Average True Range (ATR)
  • DCTH 0.41
  • HNST 0.13
  • MACD
  • DCTH -0.02
  • HNST 0.01
  • Stochastic Oscillator
  • DCTH 23.22
  • HNST 57.07

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About HNST The Honest Company Inc.

The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.

Share on Social Networks: